References
1. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J. Allergy Clin. Immunol. Pract 2013; 1: 545–56; quiz 557. DOI: https://doi.org/10.1016/j.jaip.2013.09.015
2. Maglione P.J., Ko H.M., Beasley M.B., Strauchen J.A., Cunningham-Rundles C. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol 2014; 133: 535–42. DOI: https://doi.org/10.1016/j.jaci.2013.08.022
3. Lushova A.A., Zheremyan E.A., Astakhova E.A., Spiridonova A.B., Byazrova M.G., Filatov A.V. B-lymphocyte subsets: functions and molecular markers. Immunologiya. 2019; 40 (6): 63–76. DOI: https://doi.org/10.24411/0206-4952-2019-16009 (in Russian)
4. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeson-van der Cruyssen F., Mouthon L., Chevret S., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 2003; 23: 385–400. DOI: https://doi.org/10.1023/A:1025373601374
5. Warnatz K., Denz A., Dräger R., Braun M., Groth C., Wolff-Vorbeck G., et al. Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002; 99: 1544–51. DOI: https://doi.org/10.1182/blood.V99.5.1544
6. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111: 77–85. DOI: https://doi.org/10.1182/blood-2007-06-091744
7. Bogaert D.J.A., Dullaers M., Lambrecht B.N., Vermaelen K.Y., De Baere E., Haerynck F. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J. Med. Genet 2016; 53: 575–90. DOI: https://doi.org/10.1136/jmedgenet-2015-103690
8. Ettinger R., Sims G.P., Fairhurst A.-M., Robbins R., da Silva Y.S., Spolski R., et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 2005; 175: 7867–79. DOI: https://doi.org/10.4049/jimmunol.175.12.7867
9. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 2003; 112: 286–97. DOI: https://doi.org/10.1172/JCI18025
10. Barbosa R.R., Silva S.L., Silva S.P., Melo A.C., Pereira-Santos M.C., Barata J.T., et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J. Clin. Immunol. 2014; 34: 573–83. DOI: https://doi.org/10.1007/s10875-014-0047-y
11. Matsuda Y., Haneda M., Kadomatsu K., Kobayashi T. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen. Cell. Immunol. 2015; 295: 127–36. DOI: https://doi.org/10.1016/j.cellimm.2015.02.011
12. Byazrova M.G., Astakhova E.A., Spiridonova A.B., Vasil’eva Yu.V., Prilipov A.G., Filatov A.V. IL-21/CD40L stimulation of human B-lymphocytes in vitro and their characteristics. Immunologiya. 2020; 41 (6): 18–27. DOI: https://doi.org/10.33029/0206-4952-2020-41-6-18-27 (in Russian)
13. Filatov A.V., Krotov G.I., Zgoda V.G., Volkov Y. Fluorescent immunoprecipitation analysis of cell surface proteins: A methodology compatible with mass-spectrometry. J. Immunol. Methods. 2007; 319: 21–33. DOI: https://doi.org/10.1016/j.jim.2006.09.014
14. Khvastunova A.N., Kuznetsova S.A., Al-Radi L.S., Vylegzhanina A.V., Zakirova A.O., Fedyanina O.S., et al. Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia. Sci. Rep. 2015; 5: 12573. DOI: https://doi.org/10.1038/srep12573
15. Berg E.A., Fishman J.B. Labeling antibodies with Cy5-Phycoerythrin. Cold Spring Harb. Protoc. 2019; 2019: pdb.prot099317. DOI: https://doi.org/10.1101/pdb.prot099317
16. Vira S., Mekhedov E., Humphrey G., Blank P.S. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal. Biochem 2010; 402: 146–50. DOI: https://doi.org/10.1016/j.ab.2010.03.036
17. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol 1996; 14: 591–617. DOI: https://doi.org/10.1146/annurev.immunol.14.1.591
18. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000; 67: 2–17. DOI: https://doi.org/10.1002/jlb.67.1.2
19. Revy P., Geissmann F., Debré M., Fischer A., Durandy A. Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells. Eur. J. Immunol 1998; 28: 3648–54. DOI: https://doi.org/10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.0.CO;2-U
20. Kowalczyk D., Macura-Biegun A., Zembala M. The expression of CD40 on monocytes of children with primary humoral immunodeficiencies. Pediatr. Res. 2006; 59: 816–9. DOI: https://doi.org/10.1203/01.pdr.0000219298.96471.18
21. Brugnoni D., Airò P., Lebovitz M., Malacarne F., Ugazio A.G., Notarangelo L.D., et al. CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation. Pediatr. Allergy Immunol 1996; 7: 176–9. DOI: https://doi.org/10.1111/j.1399-3038.1996.tb00129.x
22. Laberko A.L., Starichkova Yu.V., Khismatullina R.D., Persiantseva M.I., Maschan M.A., Balashov D.N., Rumyantsev A.G. Optimization of hematopoietic stem cell transplantation planning using medical information system in children with primary immunodeficiencies. Immunologiya. 2021; 42 (1): 49–59. DOI: https://doi.org/10.33029/0206-4952-2021-42-1-49-59 (in Russian)
23. Borte S., Pan-Hammarström Q., Liu C., Sack U., Borte M., Wagner U., et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood. 2009; 114: 4089–98. DOI: https://doi.org/10.1182/blood-2009-02-207423